HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 34 filers reported holding HARPOON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -38.7% | 9,287 | -6.6% | 0.00% | – |
| Q4 2021 | $75,000 | -7.4% | 9,940 | -2.9% | 0.00% | – |
| Q3 2021 | $81,000 | -44.1% | 10,238 | -2.3% | 0.00% | – |
| Q2 2021 | $145,000 | -12.1% | 10,481 | +32.7% | 0.00% | -100.0% |
| Q1 2021 | $165,000 | +58.7% | 7,896 | +26.5% | 0.00% | – |
| Q4 2020 | $104,000 | -2.8% | 6,241 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $107,000 | 0.0% | 6,323 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | +114.0% | 6,467 | +49.0% | 0.00% | – |
| Q1 2020 | $50,000 | -26.5% | 4,341 | -5.5% | 0.00% | – |
| Q4 2019 | $68,000 | +7.9% | 4,593 | +0.3% | 0.00% | – |
| Q3 2019 | $63,000 | +28.6% | 4,580 | +21.5% | 0.00% | – |
| Q2 2019 | $49,000 | +226.7% | 3,771 | +130.5% | 0.00% | – |
| Q1 2019 | $15,000 | – | 1,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $66,038,000 | 15.37% |
| MPM ASSET MANAGEMENT LLC | 3,238,306 | $67,745,000 | 13.09% |
| MPM BioImpact LLC | 3,898,422 | $81,555,000 | 10.25% |
| Aquilo Capital Management, LLC | 1,554,199 | $32,514,000 | 5.88% |
| Altium Capital Management LP | 199,607 | $4,176,000 | 1.16% |
| SECTORAL ASSET MANAGEMENT INC | 631,050 | $13,202,000 | 1.00% |
| Avidity Partners Management LP | 1,408,000 | $29,455,000 | 0.81% |
| DAFNA Capital Management LLC | 126,663 | $2,650,000 | 0.63% |
| Logos Global Management LP | 300,000 | $6,276,000 | 0.61% |
| Orbimed Advisors | 2,285,704 | $47,817,000 | 0.45% |